ID
38643
Beschrijving
Study ID: 109035 Clinical Study ID: 109035 Study Title: A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of GSK163090 in Subjects With Major Depressive Disorder Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00896363 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK163090 1 mg, GSK163090 Placebo, GSK163090 3 mg Trade Name: Study Indication: Depressive Disorder
Trefwoorden
Versies (1)
- 29-10-19 29-10-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
29 oktober 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Efficacy and Safety of GSK163090 in Subjects with Major Depressive Disorder; NCT00896363
Investigational Product
- StudyEvent: ODM
Similar models
Investigational Product
- StudyEvent: ODM
C0178602 (UMLS CUI-2)
C0332170 (UMLS CUI-3)
C0178602 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0040223 (UMLS CUI [1,5])
C0178602 (UMLS CUI-2)
C0587117 (UMLS CUI-3)
C0178602 (UMLS CUI [1,2])
C0587117 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0040223 (UMLS CUI [1,5])
C0750484 (UMLS CUI-2)
C2349182 (UMLS CUI [1,2])
C3827420 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Geen commentaren